🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Adults With Overweight and Obesity

A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity NCT07291232Phase 12 sites📍 Anaheim📍 Grayslake AbbVie · Tests: ABBV-295, Placebo A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1) NCT07823608Phase 36 sites📍 Cullman📍 Riverside📍 Bradenton Pfizer · Tests: Berobenatide, Placebo Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy NCT07336797Phase 21 site📍 Cairo Abdelrahman Mahmoud · Tests: Empagliflozin (oral), Placebo A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus NCT07784725Phase 3212 sites📍 Dothan📍 Huntsville📍 Mesa AstraZeneca · Tests: AZD6234, Placebo A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus NCT07776509Phase 396 sites📍 Escondido📍 Lincoln📍 Walnut Creek AstraZeneca · Tests: Lenbelintide, Placebo Register of Patients With Prader-Willi Syndrome NCT02829684n/a1 site📍 Toulouse University Hospital, Toulouse · Tests: Data collection PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) NCT07654361Phase 371 sites📍 Birmingham📍 Birmingham📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: Aleniglipron, Placebo A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity NCT07665879Phase 12 sites📍 Neuss📍 Mölndal Eli Lilly and Company · Tests: Eloralintide, Placebo High Phenolic Olive Oil for Enhancing Metabolic Health: a Randomized-controlled Trial in Patients With cEntral Obesity (HOPE) NCT07445503NA1 site📍 Kalamata University of Peloponnese · Tests: Low phenolic olive oil, High phenolic olive oil Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity NCT07540949NA1 site📍 Taoyuan National Taiwan Sport University · Tests: Rutazyme® Lemon Fermented Product Capsule, Placebo Capsule (Maltodextrin; GLUCIDEX®12) A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. NCT07511205Phase 13 sites📍 Glendale📍 Brooklyn📍 Harrow AstraZeneca · Tests: AZD1043, Placebo A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) NCT07654374Phase 374 sites📍 Birmingham📍 Chandler📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: aleniglipron, aleniglipron, aleniglipron, Placebo Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability NCT05744479Phase 41 site📍 Toronto Centre for Addiction and Mental Health · Tests: Metformin, Placebo, Lifestyle Intervention Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity NCT07715955NA1 site📍 Maastricht Maastricht University Medical Center · Tests: Probiotic supplementation, Placebo Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults NCT06044571NA1 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: Prescriptive, Behavioral A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW) NCT07794761Phase 334 sites📍 Chiba📍 Matsuyama📍 Matsuyama Pfizer · Tests: Berobenatide, Placebo Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight NCT07770841Phase 362 sites📍 Birmingham📍 Escondido📍 Huntington Park Novo Nordisk A/S · Tests: Semaglutide, Placebo A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight NCT07589608Phase 240 sites📍 Chandler📍 Scottsdale📍 Tucson Eli Lilly and Company · Tests: Macupatide, Eloralintide, Placebo Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity NCT06809166Phase 43 sites📍 Ottawa📍 Ottawa📍 Ottawa The Royal's Institute of Mental Health Research · Tests: Contrave, Placebo, Diet Program Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity NCT06842186Phase 1, Phase 27 sites📍 Phoenix📍 Baltimore📍 Chisinau Wave Life Sciences USA, Inc. · Tests: WVE-007 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight NCT07893093Phase 12 sites📍 San Antonio📍 Salt Lake City Ascletis Pharma (China) Co., Limited · Tests: ASC36 Injection A, for subcutaneous use, ASC36 Placebo Injection A, for subcutaneous use, ASC36 Injection B, for subcut… A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity NCT07803744Phase 11 site📍 Miami Eli Lilly and Company · Tests: Tirzepatide, Acetaminophen, Placebo Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities NCT07752979Phase 263 sites📍 Pelham📍 Scottsdale📍 Tucson AbbVie · Tests: ABBV-295, Placebo Tirzepatide for Alcohol Use Disorder NCT06994338Phase 21 site📍 Los Angeles University of Southern California · Tests: Tirzepatide, Placebo injections Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome NCT05819853Phase 31 site📍 Aurora University of Colorado, Denver · Tests: Semaglutide Injectable Product (Wegovy and/or Ozempic) Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity. NCT06636773NA1 site📍 Kansas City University of Kansas Medical Center · Tests: Diet, Aerobic Exercise, Behavioral Sessions, Aerobic + Yoga Exercise Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy NCT07728669NA1 site📍 Almaty Kazakh Academy of Nutrition · Tests: NutriSteppe Digital Dietary Intervention GROWing Up With Rare GENEtic Syndromes NCT04463316n/a1 site📍 Rotterdam dr. Laura C. G. de Graaff-Herder · Tests: Retrospective file studies
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy